What is Zacks Research’s Estimate for Danaher Q1 Earnings?

Danaher Co. (NYSE:DHR) – Investment analysts at Zacks Research reduced their Q1 2025 earnings estimates for Danaher in a research report issued to clients and investors on Tuesday, March 25th. Zacks Research analyst R. Department now expects that the conglomerate will earn $1.61 per share for the quarter, down from their prior estimate of $1.62. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q2 2025 earnings at $1.76 EPS, Q3 2025 earnings at $1.85 EPS, FY2025 earnings at $7.59 EPS, Q1 2026 earnings at $1.84 EPS and FY2026 earnings at $8.50 EPS.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business earned $2.09 EPS.

Several other equities research analysts have also weighed in on DHR. Scotiabank initiated coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Stifel Nicolaus upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research report on Friday, March 14th. The Goldman Sachs Group raised Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price target on the stock in a report on Friday, March 21st. Finally, Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective for the company. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $278.24.

Danaher Stock Down 0.1 %

Shares of Danaher stock opened at $210.26 on Thursday. Danaher has a twelve month low of $196.80 and a twelve month high of $281.70. The stock has a market capitalization of $150.27 billion, a price-to-earnings ratio of 39.82, a PEG ratio of 2.66 and a beta of 0.82. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business’s 50 day simple moving average is $215.23 and its 200-day simple moving average is $237.37.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Danaher by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after acquiring an additional 315,912 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Danaher by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock valued at $3,056,996,000 after purchasing an additional 315,446 shares in the last quarter. Norges Bank acquired a new stake in shares of Danaher in the fourth quarter worth $2,130,740,000. Bank of New York Mellon Corp grew its holdings in shares of Danaher by 5.4% during the fourth quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after buying an additional 441,012 shares in the last quarter. Finally, Northern Trust Corp raised its position in Danaher by 14.3% during the fourth quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate’s stock valued at $1,821,477,000 after buying an additional 992,594 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.61%. Danaher’s payout ratio is 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.